Abbott Laboratories (ABT) Q1 2009 Earnings Results

Abbott Labs Beats on EPS, Stock Down 4.6%

Abbott Labs reported a slight earnings beat, but the stock fell by 4.6% following the announcement. Investors may have been disappointed by the lack of revenue details and forward guidance. The cautious tone from management could indicate uncertainty in the near term, impacting investor sentiment.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.73	N/A	+3.84%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about future performance despite not providing specific guidance. They emphasized their commitment to innovation.

Management expressed confidence in the company's long-term growth prospects.

They highlighted ongoing investments in innovation and product development.

Abbott Labs Beats on EPS, Stock Down 4.6%

Key numbers

Management commentary

Abbott Laboratories

More earnings this week

Abbott Labs Beats on EPS, Stock Down 4.6%

Key numbers

Management commentary